CHI Advisors as of Sept. 30, 2022
Portfolio Holdings for CHI Advisors
CHI Advisors holds 25 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 25.4 | $95M | 1.6M | 59.01 | |
| Pliant Therapeutics (PLRX) | 19.2 | $71M | 3.4M | 20.89 | |
| Cullinan Oncology (CGEM) | 11.2 | $42M | 3.2M | 12.82 | |
| Repare Therapeutics Ord (RPTX) | 10.0 | $37M | 3.1M | 12.13 | |
| Vectivbio Hldg Ord Shs | 6.6 | $25M | 4.1M | 6.00 | |
| Kezar Life Sciences (KZR) | 4.1 | $15M | 1.8M | 8.61 | |
| Larimar Therapeutics (LRMR) | 2.9 | $11M | 3.4M | 3.20 | |
| Akouos | 2.3 | $8.7M | 1.3M | 6.76 | |
| 2seventy Bio Common Stock (TSVT) | 2.1 | $7.7M | 530k | 14.55 | |
| Keros Therapeutics (KROS) | 2.0 | $7.5M | 200k | 37.62 | |
| Compass Therapeutics (CMPX) | 1.7 | $6.5M | 2.8M | 2.28 | |
| Omega Therapeutics Common Stock (OMGA) | 1.5 | $5.7M | 1.1M | 5.42 | |
| Inozyme Pharma (INZY) | 1.4 | $5.4M | 2.0M | 2.68 | |
| Precision Biosciences Ord | 1.3 | $4.8M | 3.7M | 1.30 | |
| Ikena Oncology (IKNA) | 1.2 | $4.3M | 1.2M | 3.55 | |
| G1 Therapeutics (GTHX) | 1.1 | $4.0M | 324k | 12.49 | |
| Orchard Therapeutics Spon Ads | 1.1 | $4.0M | 8.0M | 0.50 | |
| Eiger Biopharmaceuticals | 0.9 | $3.4M | 455k | 7.53 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.9 | $3.4M | 4.8M | 0.70 | |
| Rallybio Corp (RLYB) | 0.8 | $2.8M | 194k | 14.47 | |
| Oncorus | 0.5 | $2.0M | 2.4M | 0.85 | |
| Corvus Pharmaceuticals (CRVS) | 0.5 | $2.0M | 2.4M | 0.82 | |
| Ovid Therapeutics (OVID) | 0.4 | $1.6M | 865k | 1.84 | |
| Nkarta (NKTX) | 0.4 | $1.5M | 118k | 13.16 | |
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 0.3 | $1.2M | 50k | 23.94 |
